Abstract
Cancer cells produce high levels of reactive oxygen species (ROS) that lead to a state of increased basal oxidative stress. Since this state of oxidative stress makes cancer cells vulnerable to agents that further augment ROS levels, the use of pro-oxidant agents is emerging as an exciting strategy to selectively target tumor cells. Natural products have provided a significant contribution to the development of several drugs currently used in cancer chemotherapy. Although many natural products are known to affect the redox state of the cell, most studies on these compounds have focused on their antioxidant activity instead of on their pro-oxidant properties. This article provides an overview of natural products with pro-oxidant and anticancer activities, with special focus on plant secondary metabolites, and discusses their possible use as cancer chemotherapeutic agents.
Keywords: Alkaloids, cancer, hydrogen peroxide, phenolic compounds, plant secondary metabolites, prooxidant, reactive oxygen species, terpenoids, Anticancer Agents, oxidative stress, Natural products
Current Drug Targets
Title:Pro-Oxidant Natural Products as Anticancer Agents
Volume: 13 Issue: 8
Author(s): Carmen Martin-Cordero, Antonio Jose Leon-Gonzalez, Jose Manuel Calderon-Montano, Estefania Burgos-Moron and Miguel Lopez-Lazaro
Affiliation:
Keywords: Alkaloids, cancer, hydrogen peroxide, phenolic compounds, plant secondary metabolites, prooxidant, reactive oxygen species, terpenoids, Anticancer Agents, oxidative stress, Natural products
Abstract: Cancer cells produce high levels of reactive oxygen species (ROS) that lead to a state of increased basal oxidative stress. Since this state of oxidative stress makes cancer cells vulnerable to agents that further augment ROS levels, the use of pro-oxidant agents is emerging as an exciting strategy to selectively target tumor cells. Natural products have provided a significant contribution to the development of several drugs currently used in cancer chemotherapy. Although many natural products are known to affect the redox state of the cell, most studies on these compounds have focused on their antioxidant activity instead of on their pro-oxidant properties. This article provides an overview of natural products with pro-oxidant and anticancer activities, with special focus on plant secondary metabolites, and discusses their possible use as cancer chemotherapeutic agents.
Export Options
About this article
Cite this article as:
Martin-Cordero Carmen, Jose Leon-Gonzalez Antonio, Manuel Calderon-Montano Jose, Burgos-Moron Estefania and Lopez-Lazaro Miguel, Pro-Oxidant Natural Products as Anticancer Agents, Current Drug Targets 2012; 13 (8) . https://dx.doi.org/10.2174/138945012802009044
DOI https://dx.doi.org/10.2174/138945012802009044 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity
Current Medicinal Chemistry Inflammatory Cytokines, Growth Factors, and Depression
Current Pharmaceutical Design Immunomodulatory Activity of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Meta-analysis Identifies Tumor Necrosis Factor-alpha and Interleukin-1 beta as Diagnostic Biomarkers for Bacterial and Aseptic Meningitis
Current Neurovascular Research A Targeted Therapy for Protein and Lipid Kinases in Chronic Lymphocytic Leukemia
Current Medicinal Chemistry Medicinal Plants Towards Modeling Skin Cancer
Current Drug Targets Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GW870086: Two Randomised Studies
Current Drug Therapy The Extensive Array of Obstetrical Applications of Misoprostol
Current Women`s Health Reviews Patent Selections
Recent Patents on Biomarkers Development of Ketoprofen Loaded Micro-/nanospheres Using Different Polymers
Current Nanomaterials Probiotic Research in Australia, New Zealand and the Asia-Pacific Region
Current Pharmaceutical Design Sample Preparation Techniques for Mass Spectrometry in Proteomics Using Recently Developed Highly Selective Materials
Current Proteomics Anti-cancer and Anti-angiogenic Properties of Various Natural Pentacyclic Tri-terpenoids and Some of their Chemical Derivatives
Current Organic Chemistry Gut Microbiota Might Act as a Potential Therapeutic Pathway in COVID-19
Current Pharmaceutical Biotechnology 2-Hydroxy-1-oxo-1,2-dihydroisoquinoline-3-carboxylic Acid with Inbuilt β-N-Hydroxy-γ-keto-acid Pharmacophore as HCV NS5B Polymerase Inhibitors
Current Medicinal Chemistry Low 25 Hydroxyvitamin D Levels are Independently Associated with Autoimmune Thyroiditis in a Cohort of Apparently Healthy Overweight and Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Strategies and Tools for Enhanced Sensitivity in Routine Biomolecule Analytics
Current Pharmaceutical Analysis Simultaneous Amplification of HER-2 (ERBB2) and Topoisomerase IIα (TOP2A) Genes - Molecular Basis for Combination Chemotherapy in Cancer
Current Cancer Drug Targets ABCC6 as a Target in Pseudoxanthoma Elasticum
Current Drug Targets Animal Models for Studying Neointima Formation
Current Vascular Pharmacology